Actively Recruiting
Active Surveillance for Cancer of the Prostate (ASCaP)
Led by Jonsson Comprehensive Cancer Center · Updated on 2025-05-13
462
Participants Needed
1
Research Sites
1012 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Active Surveillance (A.S.) of prostate cancer (CaP) is the systematic monitoring of men with low-risk, localized lesions, with curative treatment of those whose tumors show substantial progression. A.S. is different from Watchful Waiting (W.W.), which is the palliative treatment of men with progressive prostate cancer.
CONDITIONS
Official Title
Active Surveillance for Cancer of the Prostate (ASCaP)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically confirmed adenocarcinoma of the prostate.
- Clinically localized prostate cancer: T1-2, NX or N0, MX or M0.
- No previous treatment for prostate cancer (including hormonal therapy, radiation therapy, surgery, or chemotherapy).
- Patient has elected Active Surveillance as preferred management plan for prostate cancer.
- Patient consent has been obtained according to local Institutional Review Board.
- Patient is accessible and compliant for follow-up.
You will not qualify if you...
- Unwillingness or inability to undergo serial prostate biopsy.
- Overall life expectancy less than 2 years.
- Advanced prostate cancer.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California Los Angeles
Los Angeles, California, United States, 90095
Actively Recruiting
Research Team
M
Malu Macairan
CONTACT
L
Leonard S Marks, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here